Get the Stockscreener App
2.79
1.45%
0.04
Pre-market:
2.78
-0.01
-0.36%
Redhill Biopharma Ltd Adr Stock (RDHL) Forecast
The Redhill Biopharma Ltd Adr (RDHL) stock price forecast for the next 30 days is generally positive, with an average analyst price target of $81.24, representing a +2,812% increase from the current price of $2.79. The highest analyst price target is $74.02, and the lowest is $88.45.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month RDHL Price Target
Average 113.84
(+3,980% Upside)
Is Redhill Biopharma Ltd Adr (RDHL) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 32.45 | Neutral |
| STOCH(9,6) | 50.51 | Neutral |
| STOCHRSI(14) | 88.39 | Sell |
| MACD(12,26) | -0.4583 | Buy |
| ADX(14) | 42.09 | Sell |
| William %R | -54.81 | Neutral |
| CCI(14) | -9.455 | Neutral |
Buy: 1
Sell: 2
Neutral: 4
Summary: Neutral
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
2.8444
Sell
|
2.8482
Sell
|
| MA20 |
2.9153
Sell
|
3.1279
Sell
|
| MA50 |
4.4389
Sell
|
4.1735
Sell
|
| MA100 |
5.7712
Sell
|
5.5388
Sell
|
| MA200 |
7.6066
Sell
|
8.3682
Sell
|
Buy: 0
Sell: 10
Neutral: 0
Summary: Sell
According to our latest analysis, RDHL could be considered a Strong Sell, with 17 technical analysis indicators signaling 1 Buy signals, 12 signaling Sell signals and 4 Neutral signals. This might not be a good time to consider opening new positions on RDHL, as trading bearish markets can be challenging and may result in losses.
- RSI (Relative Strength Index): The RSI(14) value of 32.45 indicates that RDHL is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
- STOCH (Stochastic Oscillator): The STOCH value of 50.51 indicates that RDHL is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 88.39 indicates that RDHL is oversold. This suggests that RDHL price is at or near the highest level relative to its recent price history.
- ADX (Average Directional Index): The ADX value of The ADX value of 42.09 suggests a moderate trend in the market. It indicates that there is more conviction behind the directional movement compared to lower ADX values. You should consider this as a potential opportunity to enter trades in the direction of the trend.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of -9.455 indicates that RDHL is not in oversold or overbought territory. It suggests a neutral sentiment in the short term.
Long-term RDHL price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Redhill Biopharma Ltd Adr financial reports and earnings history, Redhill Biopharma Ltd Adr (RDHL) stock could reach $314.53 by 2030, $203.19 by 2040 and $605.09 by 2050. See the projected annual prices until 2050 of the Redhill Biopharma Ltd Adr stock below:
- Redhill Biopharma Ltd Adr (RDHL) is expected to reach an average price of $59.77 in 2035, with a high prediction of $68.03 and a low estimate of $59.77. This indicates an $2,042% rise from the last recorded price of $2.79.
- Redhill Biopharma Ltd Adr (RDHL) stock is projected to chart a bullish course in 2040, with an average price target of $195.49, representing an $6,907% surge from its current level. The forecast ranges from a conservative $195.74 to a sky-high $203.19.
- Our analysts predict Redhill Biopharma Ltd Adr (RDHL) to jump 13,574% by 2045, soaring from $383.95 to an average price of $381.50, potentially reaching $383.73. While $383.95 is the low estimate, the potential upside is significant.
- Redhill Biopharma Ltd Adr (RDHL) stock is expected to climb by 2050, reaching an average of $575.80, a $20,538% jump from its current level. However, a wide range of estimates exists, with high and low targets of $605.09 and $609.25, respectively, highlighting the market's uncertainty.
Redhill Biopharma Ltd Adr Stock (RDHL) Year by Year Forecast
Redhill Biopharma Ltd Adr Stock (RDHL) Price Forecast for 2025
Redhill Biopharma Ltd Adr Stock (RDHL) is expected to reach an average price of $113.84 in 2025, with a high prediction of $226.34 and a low estimate of $1.3453. This indicates an +3,980% rise from the last recorded price of $2.79.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| April, 2025 | $76.05 | $88.45 | $74.02 | +2,626% |
| May, 2025 | $33.37 | $13.37 | $75.52 | +1,096% |
| June, 2025 | $20.00 | $1.3453 | $112.83 | +616.92% |
| July, 2025 | $26.09 | $13.32 | $63.43 | +834.98% |
| August, 2025 | $30.71 | $15.14 | $72.20 | +1,001% |
| September, 2025 | $114.94 | $4.1701 | $128.54 | +4,020% |
| October, 2025 | $67.82 | $56.62 | $172.80 | +2,331% |
| November, 2025 | $183.25 | $71.48 | $226.34 | +6,468% |
| December, 2025 | $114.14 | $101.54 | $212.28 | +3,991% |
Redhill Biopharma Ltd Adr Stock (RDHL) Price Forecast for 2026
The predicted value for Redhill Biopharma Ltd Adr (RDHL) in 2026 is set at an average of $138.45. Estimates vary from a peak of $276.61 to a trough of $0.2891, indicating an +4,862% surge from the present price of $2.79.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2026 | $137.96 | $91.45 | $162.51 | +4,845% |
| February, 2026 | $130.19 | $109.93 | $152.99 | +4,566% |
| March, 2026 | $89.62 | $66.42 | $188.85 | +3,112% |
| April, 2026 | $234.10 | $93.47 | $246.10 | +8,291% |
| May, 2026 | $102.73 | $77.01 | $259.56 | +3,582% |
| June, 2026 | $98.56 | $70.16 | $115.77 | +3,432% |
| July, 2026 | $60.24 | $47.84 | $102.41 | +2,059% |
| August, 2026 | $108.47 | $55.70 | $121.67 | +3,788% |
| September, 2026 | $81.75 | $68.95 | $111.12 | +2,830% |
| October, 2026 | $110.38 | $58.01 | $113.46 | +3,856% |
| November, 2026 | $233.41 | $88.09 | $276.61 | +8,266% |
| December, 2026 | $17.89 | $0.2891 | $255.13 | +541.19% |
Redhill Biopharma Ltd Adr Stock (RDHL) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Redhill Biopharma Ltd Adr (RDHL) is $53.73, with a high forecast of $98.92 and a low forecast of $8.5459. This indicates an +1,826% increase from the last price of $2.79.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $71.72 | $8.5459 | $98.92 | +2,470% |
| February, 2027 | $43.66 | $34.09 | $83.97 | +1,465% |
| March, 2027 | $45.57 | $46.74 | $36.17 | +1,533% |
| April, 2027 | $48.55 | $52.12 | $42.95 | +1,640% |
| May, 2027 | $41.92 | $46.32 | $44.43 | +1,402% |
| June, 2027 | $68.63 | $50.06 | $49.43 | +2,360% |
| July, 2027 | $32.81 | $33.21 | $57.98 | +1,076% |
| August, 2027 | $48.18 | $32.95 | $42.18 | +1,627% |
| September, 2027 | $81.30 | $62.72 | $81.30 | +2,814% |
| October, 2027 | $94.43 | $80.24 | $84.67 | +3,285% |
| November, 2027 | $76.44 | $82.63 | $81.90 | +2,640% |
| December, 2027 | $67.96 | $73.16 | $76.87 | +2,336% |
Redhill Biopharma Ltd Adr Stock (RDHL) Price Forecast for 2028
In 2028, Redhill Biopharma Ltd Adr (RDHL) is projected to reach an average price of $67.11, with a high projection of $79.97 and a low estimate of $54.24. This indicates an +2,305% rise from the last price of $2.79.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $71.47 | $70.38 | $70.79 | +2,462% |
| February, 2028 | $81.80 | $71.87 | $76.50 | +2,832% |
| March, 2028 | $68.78 | $70.58 | $76.56 | +2,365% |
| April, 2028 | $76.96 | $70.74 | $72.79 | +2,658% |
| May, 2028 | $80.77 | $78.13 | $79.97 | +2,795% |
| June, 2028 | $75.98 | $76.28 | $79.70 | +2,623% |
| July, 2028 | $70.25 | $70.65 | $71.58 | +2,418% |
| August, 2028 | $65.45 | $65.73 | $68.40 | +2,246% |
| September, 2028 | $65.88 | $65.92 | $65.35 | +2,261% |
| October, 2028 | $62.77 | $62.87 | $64.60 | +2,150% |
| November, 2028 | $57.50 | $57.54 | $61.31 | +1,961% |
| December, 2028 | $54.20 | $54.24 | $56.39 | +1,843% |
Redhill Biopharma Ltd Adr Stock (RDHL) Price Forecast for 2029
The 2029 price forecast for Redhill Biopharma Ltd Adr Stock (RDHL) is $145.68 on average, with a high prediction of $290.30 and a low estimate of $1.0701. This represents an +5,122% increase from the previous price of $2.79.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $48.84 | $48.88 | $53.06 | +1,651% |
| February, 2029 | $44.98 | $45.01 | $47.73 | +1,512% |
| March, 2029 | $40.82 | $40.88 | $43.92 | +1,363% |
| April, 2029 | $37.12 | $37.18 | $39.59 | +1,230% |
| May, 2029 | $31.85 | $31.85 | $35.60 | +1,041% |
| June, 2029 | $26.27 | $26.35 | $30.72 | +841.47% |
| July, 2029 | $22.24 | $22.33 | $24.87 | +697.13% |
| August, 2029 | $17.84 | $17.86 | $21.10 | +539.28% |
| September, 2029 | $13.65 | $13.68 | $16.76 | +389.29% |
| October, 2029 | $8.4229 | $8.4341 | $12.48 | +201.90% |
| November, 2029 | $4.2255 | $4.3775 | $7.298 | +51.45% |
| December, 2029 | $310.70 | $1.0701 | $290.30 | +11,036% |
Redhill Biopharma Ltd Adr Stock (RDHL) Price Forecast for 2030
Redhill Biopharma Ltd Adr Stock (RDHL) is expected to reach an average price of $307.69 in 2030, with a high forecast of $334.45 and a low forecast of $280.94. This signifies an +10,928% surge from the last price of $2.79.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $323.73 | $322.47 | $314.53 | +11,503% |
| February, 2030 | $307.28 | $337.62 | $330.30 | +10,913% |
| March, 2030 | $322.82 | $297.16 | $316.93 | +11,471% |
| April, 2030 | $283.17 | $308.37 | $312.19 | +10,049% |
| May, 2030 | $294.20 | $280.94 | $283.20 | +10,445% |
| June, 2030 | $315.34 | $301.29 | $291.57 | +11,203% |
| July, 2030 | $320.38 | $289.92 | $301.98 | +11,383% |
| August, 2030 | $315.12 | $304.24 | $296.33 | +11,195% |
| September, 2030 | $296.27 | $305.07 | $296.29 | +10,519% |
| October, 2030 | $329.30 | $301.75 | $326.10 | +11,703% |
| November, 2030 | $346.85 | $359.36 | $334.45 | +12,332% |
| December, 2030 | $321.99 | $335.99 | $329.82 | +11,441% |
0.95%
0.05%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):